Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
12.08
+0.50 (4.32%)
At close: Feb 4, 2025, 4:00 PM
11.22
-0.86 (-7.12%)
Pre-market: Feb 5, 2025, 6:25 AM EST
COEP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | 0.08 | 0.03 | 0.02 | |
| Revenue Growth (YoY) | - | - | - | 143.82% | 27.68% | -91.49% | |
| Cost of Revenue | - | - | - | - | 0.96 | - | |
| Gross Profit | - | - | - | 0.08 | -0.93 | 0.02 | |
| Selling, General & Admin | 7.8 | 14.82 | 34.18 | 14.12 | 5.78 | 3.05 | |
| Research & Development | 3 | 6.67 | 0.02 | - | 0 | 1.38 | |
| Operating Expenses | 11.26 | 21.49 | 34.2 | 14.12 | 5.78 | 4.43 | |
| Operating Income | -11.26 | -21.49 | -34.2 | -14.05 | -6.71 | -4.41 | |
| Interest Expense | -0.33 | -0.11 | -0.22 | -0.19 | -0.15 | -0.01 | |
| Other Non Operating Income (Expenses) | 0.01 | 0.33 | 0.01 | 0.79 | -2.29 | - | |
| EBT Excluding Unusual Items | -11.58 | -21.27 | -34.41 | -13.45 | -9.16 | -4.42 | |
| Gain (Loss) on Sale of Assets | -0.04 | - | - | -0 | - | 2.31 | |
| Other Unusual Items | - | - | -3.17 | - | - | - | |
| Pretax Income | -11.62 | -21.27 | -37.57 | -13.45 | -9.16 | -2.11 | |
| Net Income | -11.62 | -21.27 | -37.57 | -13.45 | -9.16 | -2.11 | |
| Net Income to Common | -11.62 | -21.27 | -37.57 | -13.45 | -9.16 | -2.11 | |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 68.81% | 79.70% | 30.98% | 79.11% | 18.53% | 1.63% | |
| EPS (Basic) | -6.33 | -16.56 | -52.57 | -24.64 | -30.05 | -8.19 | |
| EPS (Diluted) | -6.33 | -16.56 | -52.57 | -24.64 | -30.05 | -8.19 | |
| Free Cash Flow | -6.91 | -7.24 | -3.88 | -4.49 | -3.14 | -3.57 | |
| Free Cash Flow Per Share | -3.76 | -5.64 | -5.42 | -8.23 | -10.29 | -13.87 | |
| Gross Margin | - | - | - | 100.00% | - | 100.00% | |
| Operating Margin | - | - | - | -18727.91% | -21823.77% | -18294.32% | |
| Profit Margin | - | - | - | -17932.37% | -29765.89% | -8741.29% | |
| Free Cash Flow Margin | - | - | - | -5985.92% | -10195.12% | -14800.13% | |
| EBITDA | -10.26 | -20.49 | -33.19 | -13.6 | -6.39 | -4.37 | |
| D&A For EBITDA | 1 | 1 | 1 | 0.45 | 0.32 | 0.03 | |
| EBIT | -11.26 | -21.49 | -34.2 | -14.05 | -6.71 | -4.41 | |
| Revenue as Reported | - | - | - | 0.08 | 0.03 | 0.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.